TELESIS BIO INC (TBIO)
US1920032000 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to TBIO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.08. This target is 26.32% above the current price.
TBIO was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about TBIO.
In the previous month the buy percentage consensus was at a similar level.
TBIO was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-11 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2021-08-04 | Roth Capital | Maintains | Neutral |
| 2021-08-03 | William Blair | Downgrade | Outperform -> Market Perform |
| 2021-08-03 | SVB Leerink | Maintains | Market Perform |
| 2021-07-26 | Roth Capital | Maintains | Buy |
| 2021-05-10 | SVB Leerink | Maintains | Market Perform |
| 2021-03-23 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2021-03-18 | SVB Leerink | Maintains | Outperform |
| 2021-03-18 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2021-03-18 | Roth Capital | Maintains | Buy |
| 2021-03-18 | Truist Securities | Downgrade | Buy -> Hold |
| 2021-03-18 | HC Wainwright & Co. | Maintains | Buy |
| 2021-03-01 | SVB Leerink | Maintains | Outperform |